Axcelis Technologies reports developments tied to its role as a supplier of ion implantation systems and process applications for semiconductor manufacturing. Company updates commonly cover quarterly results, demand trends across memory, power, compound semiconductor and mature-node markets, and the performance of its customer support and installed-base services business.
News also includes technical participation at semiconductor industry conferences, lifecycle support for Purion-based implant platforms, sustainability targets for greenhouse gas emissions, investor-conference activity and governance changes such as finance leadership transitions. The recurring business context centers on equipment used in integrated-circuit fabrication and aftermarket services including spare parts, upgrades, maintenance and training.
Axcelis Technologies (ACLS) will participate in the 23rd International Conference on Silicon Carbide and Related Materials (ICSCRM 2026) in Yokohama, Japan, from September 28 to October 2, 2026.
The company will host an exhibit at Booth #F3 and its technologists and collaborators will present multiple papers on silicon carbide ion implantation, including stacking fault suppression, contact engineering, manufacturability of 1200V superjunction pillars, and MOSFET performance sensitivity. The company highlights its Purion Power Series+™ platform for SiC power devices and cites Yole Group’s estimate that the silicon carbide device market may reach $11 billion by 2031, growing at a 20% CAGR from 2025 to 2031.
Axcelis Technologies (ACLS) will be a Platinum Sponsor of the 25th International Conference on Ion Implantation and Annealing Technology (IIT 2026), held September 20-24, 2026 at the Congress Center Villach in Austria.
The company will host an exhibit at Booth #7 and its technologists and collaborators will present on topics including implant innovation, SiC MOSFET manufacturing, aluminum ion implantation performance, implant platform developments such as realtime beam shape monitoring and beam energy measurement, wafer backside particle reduction, and emerging research in advanced CMOS contact module engineering and resonator devices. Axcelis' president and CEO said the company is committed to enabling next-generation semiconductor device manufacturing with its ion implantation technologies. Additional event and registration details are available on the IIT 2026 conference website.
Axcelis Technologies (ACLS)/b) plans to invest $35 million to build a new ion implantation equipment manufacturing facility in Pyeongtaek, Gyeonggi Province, Korea.The project expands Axcelis' global high-volume manufacturing infrastructure to better support growing semiconductor demand. The company said production at the new facility is scheduled to begin in the second half of 2028, following a groundbreaking ceremony planned for October 20, 2026.
Axcelis Technologies (NASDAQ: ACLS) announced it will participate in two upcoming investor conferences in New York. The company plans to attend the Citi 2026 Global TMT Conference on Tuesday, September 8 at the New York Hilton Midtown and the B. Riley Securities Consumer & TMT Conference on Thursday, September 10 at the InterContinental New York Times Square. Axcelis highlights its 45-plus years of providing ion implantation solutions for the semiconductor industry and lists dedicated investor relations and media contacts for further information.
Axcelis (Nasdaq: ACLS) reported second quarter 2026 revenue of $215.2 million, up from $194.5 million a year earlier. GAAP gross margin was 42.4% and operating margin 9.4%, yielding GAAP net income of $23.3 million and diluted EPS of $0.75. Non-GAAP diluted EPS was $1.06.
Non-GAAP operating margin was 14.7% with Adjusted EBITDA of $36.0 million. For Q3 2026, Axcelis expects revenue of about $230 million, GAAP EPS of $0.76 and non-GAAP EPS of $1.11. The company continues to incur integration costs tied to its pending merger with Veeco, expected to close in the second half of 2026.
Axcelis (NASDAQ: ACLS), a supplier of ion implantation solutions for the semiconductor industry, announced it will participate in two investor conferences in August. The company plans to attend the KBCM Technology Leadership Forum on Monday, August 10 at the Montage Deer Valley in Park City, Utah, and the 7th Annual Needham Virtual Semiconductor & SemiCap 1x1 Conference on Thursday, August 20.
Axcelis, headquartered in Beverly, Massachusetts, has provided semiconductor process solutions for over 45 years and supports the full life cycle of ion implantation systems. Investor relations and media contact details are provided for stakeholders seeking more information.
Axcelis (Nasdaq: ACLS) announced the successful evaluation closure of its Purion XEmax high energy implanter at a leading semiconductor foundry on July 28, 2026. The qualified system will be used in production of Power Management Integrated Circuits (PMICs), an emerging application requiring advanced 15 MeV implant capability.
According to Axcelis, Purion XEmax features a dual LINAC design with patented Boost Technology, enabling the industry's highest implant energies up to 15 MeV and metals reduction for next generation devices. It is part of the Purion XE Series, which offers a range of high energy ion implanters tailored for different power and high-volume applications.
Axcelis (Nasdaq: ACLS) will release its second quarter 2026 financial results before the market opens on Thursday, August 6, 2026. The company will host a conference call the same day at 8:30 a.m. ET, with live webcast and a replay available for 30 days via the Axcelis investors website.
Axcelis (NASDAQ: ACLS) plans to participate in several investor conferences in May and June 2026. Events include J.P. Morgan, B. Riley, Stifel, and Bank of America technology-focused conferences in Boston, Marina del Rey, and San Francisco, offering investors access to management and company updates.
Axcelis (Nasdaq: ACLS) reported Q1 2026 results: revenue $199.0M, GAAP gross margin 40.5%, GAAP operating margin 4.0%, GAAP EPS $0.30 and non-GAAP EPS $0.72. The company ended the quarter with about $570M cash and reiterated 2026 revenue is expected to be relatively flat vs 2025. Axcelis expects the Veeco merger to close in the second half of 2026.